# Korio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/korio

- Industry: Healthcare IT
- Headquarters: Doylestown, US
- Website: www.korioclinical.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Sep 10, 2024)
- Investors on record: 3

## About

Based in Pennsylvania, US, and founded in 2021 by its CEO Ryan Keane, and COO Chuck Harris, Korio Inc. operates as a company in the field of clinical trial management, offering interactive response technology (IRT) solutions. In September 2023, Korio Inc. raised USD 6.8 million in venture funding led by Boston Millennia Partners, with participation from Excelerate Health Ventures. Other unspecified investors also participated in the round. 


Korio Inc. develops an interactive response technology platform that offers subject and supply management for all trial designs, reduces customer time and effort, enhances quality, and accessible audit trails. The platform promotes study setup reusability, enabling the automatic reuse of study settings and system configurations from previous clinical trials. It also offers roles-based navigation, auto-generation of IRT requirements, and an integrations setup wizard to sync data with clinical systems more efficiently.

The company plans to use the venture funding to expand the adoption of its advanced clinical trial software platform.

## Funding rounds

- Series A, Sep 10, 2024 — Boston Millennia Partners, BIP Ventures, Excelerate Health Ventures
- Seed, Sep 15, 2023, $3.5M — Boston Millennia Partners, Excelerate Health Ventures

## Investors

- Boston Millennia Partners (https://capitalatlas.ai/funds/boston-millennia-partners) — Seed, Series A
- Excelerate Health Ventures (https://capitalatlas.ai/funds/excelerate-health-ventures) — Seed, Series A
- BIP Ventures (https://capitalatlas.ai/funds/bip-ventures) — Series A